Patrizio Mattei

USPTO Granted Patents = 75 (Patent Applications = 26)

CIPO Patents = 3 (Patent Applications = 17)

EPO Patents = 36 (Patent Applications = 41)

Average Co-Inventor Count = 6.0

ph-index = 11

Forward Citations = 507(Granted Patents)

Forward Citations (Not Self Cited) = 366(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Riechen, CH (2009)
Richen, CH (2013)
Riehen, CH (2003 - 2021)
Basel, CH (2020 - 2023)

Company Filing History:

72 out of 4,945

Hoffmann-la Roche Inc.

patents

2 out of 43

Vernalis Research Limited

patents

1 out of 1

Vernal Research Limited

Basilea Pharmaceutica Ag

patents

6. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2023

Loading Chart...

Areas of Expertise:

Peptide Macrocycles

Bicyclic Compounds

Autotaxin Inhibitors

Lysophosphatidic Acid

Heterocyclic Compounds

Diazaspirocycloalkane

GPBAR1 Agonists

CPT2 Inhibitors

Pyrido Isoquinoline Derivatives

Indazole Derivatives

Sulfonamide Derivatives

Phenoxymethyl Derivatives

75 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11819532 - Peptide macrocycles against (2023-11-21),

2. 11673888 - Bicyclic compounds as ATX inhibitors (2023-06-13),

3. 11505573 - Peptide macrocycles against (2022-11-22),

4. 11352330 - Phenoxymethyl derivatives (2022-06-07),

5. 11098048 - Bicyclic compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors (2021-08-24),

6. 11059794 - Heterocyclic compounds useful as dual ATX/CA inhibitors (2021-07-13),

7. 10913745 - Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitors (2021-02-09),

8. 10889588 - Bicyclic compounds as dual ATX/CA inhibitors (2021-01-12),

9. 10882857 - Bicyclic compounds as ATX inhibitors (2021-01-05),

10. 10849881 - Octahydro-cyclobuta[1,2-c;3,4-c']dipyrrol-2-yl (2020-12-01),

11. 10800786 - Bicyclic compounds as ATX inhibitors (2020-10-13),

12. 10787459 - Bicyclic compounds as ATX inhibitors (2020-09-29),

13. 10738053 - Bicyclic compounds as dual ATX/CA inhibitors (2020-08-11),

14. 10676446 - Bicyclic quinazolinone derivatives (2020-06-09),

15. 10669285 - Condensed [1,4] diazepine compounds as autotaxin (ATX) and lysophosphatidic acid (LPA) production inhibitors (2020-06-02),

Title: The Innovative Journey of Inventor Patrizio Mattei

Introduction: Patrizio Mattei, a distinguished inventor hailing from Riehen, Switzerland, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Patrizio Mattei's latest patents include cutting-edge technologies in the fields of renewable energy, sustainable materials, and advanced robotics, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a career spanning over two decades, Patrizio Mattei has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His inventions have not only revolutionized industries but have also improved the quality of life for many around the globe.

Collaborations: Throughout his career, Patrizio Mattei has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many of his projects.

Conclusion: In conclusion, Patrizio Mattei's relentless pursuit of innovation and his passion for creating technologies that make a difference have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of innovators to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.